AGRX

Agile Therapeutics
AGRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

16 hedge funds and large institutions have $426K invested in Agile Therapeutics in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

75% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 8

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$360K
2
+$32K
3
+$8K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$2K
5
UBS Group
UBS Group
Switzerland
+$71

Top Sellers

1
-$92.2K
2
-$53.4K
3
-$27K
4
ASN
Advisory Services Network
Georgia
-$18.3K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$17.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$360K
2
$32K
3
$17.9K
4
$8K
5
$5.17K
6
$2K
7
$534
8
$133
9
$71
10
$48
11
$30
12
$30
13
$21
14
$15
15
$3
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2